Working Title taps Joe Wright to direct Abi Morgan’s Juice adaptation from Tim Winton

Working Title Films has moved fast on a major literary property, attaching two awards-heavy creatives to bring Tim Winton’s post-apocalyptic thriller novel Juice to the big screen. Two-time BAFTA-winning filmmaker Joe Wright is set to direct, with Abi Morgan, a BAFTA and Emmy winner known for The Hour, Shame, and The Iron Lady, adapting.

The setup matters because this is not a “maybe we’ll see” development. Working Title has optioned the rights to Juice and has already put Wright and Morgan into the same creative pipeline, which is exactly how major studios reduce uncertainty early. For decision-makers, that combination is a signal: the project is being treated like it should clear the market’s highest bar, not like a low-cost test.

Zoom out and Juice is the kind of book that naturally attracts high-stakes film attention. Tim Winton’s novel centers on a post-apocalyptic thriller premise, which typically comes with two development realities. First, you need a director who can translate existential, world-building tension into visuals and performance without making the story feel like pure spectacle. Second, you need a screen adaptation that can handle tone, pace, and character pressure over the long arc of a feature. Putting Joe Wright in the director seat hints that Working Title is aiming for cinematic authorship, not just genre execution.

For Working Title and its partners, the incentive structure is straightforward. Optioning rights is the formal step that turns “interest” into “ownership of forward momentum.” Once rights are secured, the next job is to keep creative talent from slipping away. Having an attached director (Wright) and an identified adapter (Morgan) does that. It turns what would otherwise be an open-ended negotiation into an organized production plan, which helps the project survive the industry’s constant churn: changing release calendars, shifting financing priorities, and internal slate reshuffles.

The names here also come with a reputational multiplier that plays out behind the scenes. Wright’s track record as a BAFTA winner, and Morgan’s recognition as both a BAFTA and an Emmy winner, reduces perceived risk for the people who fund and distribute films. In film development, “risk” is not only about whether the story will work. It is also about whether the package will attract further backing, whether insurers and lenders will feel comfortable, and whether sales agents can credibly market the project at the start of the financing window.

That is where boards and senior executives quietly pay attention. When a company like Working Title adds director and writer talent early, it often indicates confidence in the material and in the viability of the final script. It can also change internal dynamics. Slate committees tend to prioritize projects that look “complete enough” to keep talent engaged while they line up other pieces like production design, casting, and international co-financing. In other words, the attachment stage is not ceremonial. It is a leverage point.

There is also a craft-and-market implication for anyone tracking the genre pipeline. Post-apocalyptic thrillers are recurring audience magnets, but they are notoriously hard to get right because the world must feel specific, not generic. The adaptation has to balance dread and momentum. That is why Morgan being named as the screenwriter is more than a credit line. An established adapter can translate the novel’s voice into a screenplay that maintains tension across scenes, rather than collapsing into exposition.

For peers in the development world, Juice is a reminder that competitive advantage often shows up before cameras roll. The industry tends to reward early clarity: option rights secured, a director attached, and a writer assigned. This combination makes it easier to build a coherent package for investors and distributors, and it helps projects move from concept to credible pre-production planning. If Working Title follows through, Juice could become one of those prestige genre plays that invites not only viewers, but also serious industry attention from the people who decide what gets financed next.